Estadísticas de Survival outcomes according to TIMP1 and EGFR expression in heavily treated patients with advanced non-small cell lung cancer who received biweekly irinotecan plus bevacizumab
Visitas totales
| views | |
|---|---|
| Survival outcomes according to TIMP1 and EGFR expression in heavily treated patients with advanced non-small cell lung cancer who received biweekly irinotecan plus bevacizumab | 0 |
Visitas totales por mes
| views | |
|---|---|
| abril 2024 | 0 |
| mayo 2024 | 0 |
| junio 2024 | 0 |
| julio 2024 | 0 |
| agosto 2024 | 0 |
| septiembre 2024 | 0 |
| octubre 2024 | 0 |